Bellwether Magazine
Volume 1
Number 64 Spring 2006*

Article 2

Spring 2006

Anatomy of a Stem Cell
Susan I. Finkelstein
University of Pennsylvania

Follow this and additional works at: https://repository.upenn.edu/bellwether

Recommended Citation
Finkelstein, Susan I. (2006) "Anatomy of a Stem Cell," Bellwether Magazine: Vol. 1 : No. 64 , Article 2.
Available at: https://repository.upenn.edu/bellwether/vol1/iss64/2

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/bellwether/vol1/iss64/2
For more information, please contact repository@pobox.upenn.edu.

NUMBER 63 | SPRING 2006

T H E N E W S M A G A Z I N E O F T H E U N I V E R S I T Y O F P E N N S Y LV A N I A S C H O O L O F V E T E R I N A R Y M E D I C I N E

ANATOMY
OF A

STEM CELL

Many Species. One Medicine.™

Many Species. One Medicine.™
OFFICE OF DEVELOPMENT, ALUMNI
RELATIONS AND COMMUNICATION

contents spring 

assistant dean of advancement
and communication
KATE JUDGE

director of communication
GAIL LUCIANI

assistant director of communication
SUSAN I. FINKELSTEIN

L

director of development for the
matthew j. ryan veterinary hospital
ELANA BECK ARONS

director of development for new bolton center
JANE SIMONE

major gifts officer
DORI MYERS





special event coordinator
COREEN HAGGERTY

PATRICIA HALL

marketing communication coordinator
for new bolton center
JENNIFER RENCH

constituent relations coordinator
ELIZABETH McNAMARA
assistants
KAREN COGHLAN
JOHN DONGES
ANDREA WITHERS
JENNIFER WORDEN

photographers
JOHN DONGES
SABINA LOUISE PIERCE

writers
ALAN ATCHISON
SUSAN I. FINKELSTEIN
KATHY KRUGER
NANCY WEST

designer
ANNE MARIE KANE

We’d like to hear your praise, criticisms
or comments.
Please address your correspondence to:
Gail Luciani, Editor
University of Pennsylvania
School of Veterinary Medicine
3800 Spruce Street
Philadelphia, PA 19104-6010
(215) 898-1475
luciani@vet.upenn.edu
None of these articles is to be reproduced in
any form without the permission of the editor
of Bellwether.
C Printed on recycled paper
© Copyright 2006 by the Trustees of the University of
Pennsylvania. The University of Pennsylvania values
diversity and seeks talented students, faculty and staff
from diverse backgrounds. The University of
Pennsylvania does not discriminate on the basis of race,
sex, sexual orientation, gender identity, religion, color,
national or ethnic origin, age, disability, or status as a
Vietnam Era Veteran or disabled veteran in the administration of educational policies, programs or activities;
admissions policies; scholarship and loan awards; athletic, or other University administered programs or
employment. Questions or complaints regarding this
policy should be directed to: Executive Director, Office
of Affirmative Action and Equal Opportunity Programs,
Sansom Place East, 3600 Chestnut Street, Suite 228,
Philadelphia, PA 19104-6106 or by phone at (215) 8986993 (Voice) or (215) 898-7803 (TDD).

bellwether

development coordinator for new bolton center

ab out th e c over :

f ea tures
6

ANATOMY OF A STEM CELL

10

THE HOUSE THAT JACK BUILT

12

COMBATING JOHNE’S DISEASE

d ep a r tm ents
3

EDITORIAL NOTES

4

DEAN’S MESSAGE

14

ALUMNI PROFILE

22

RESEARCH BRIEFS

25

SCHOOL EVENTS

Color-enhanced scanning electron micrograph of a stem cell collected
from human bone marrow. Most tissues contain primitive cells, called stem cells, that can divide and
populate tissue to correct damage. Bone marrow retains the ability to generate stem cells throughout life.
Bone marrow stem cells typically give rise to bone, blood and cartilage. Photo by Andrew Paul Leonard /
Photo Researchers, Inc.



anatomy of a stem cell
Penn Veterinarians
Study the Big
Future for This
Little Cell
BY SUSAN I. FINKELSTEIN

The process of discovery is very
simple. An unwearied and
systematic application of known
laws to nature causes the
unknown to reveal themselves.

—Henry David Thoreau
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ealing,Teaching and Discovery.”
Undoubtedly, the general public
is most familiar with the first part
of the School of Veterinary
Medicine’s tri-fold mission—and
with good reason.The Matthew
J. Ryan Veterinary Hospital in
Philadelphia sees more than
28,000 companion-animal patient
visits each year, 12,000 of which
come through the Emergency Service.The George D.
Widener Hospital for Large Animals at New Bolton Center
accommodates more than 6,000 patient visits annually, and the
Hospital’s William Boucher Field Service sees more than
19,000 animals a year. Both Hospitals are known
internationally for their excellence in veterinary medical
specialties, many of which originated here: cardiology,
orthopaedics, oncology and medical genetics, to name only a
few. Dogs, cats, birds, reptiles, horses, cows, pigs—all these, and
more, can receive comprehensive treatment at Penn Veterinary
Medicine, perhaps the best care anywhere in the world.
Most people are not aware, though, that the Discovery component of our mission undergirds the Healing and the Teaching
for which the School is internationally acclaimed. Knowledge
that emerges from the basic and clinical research of our scientists allows us to develop new ways to diagnose and treat disease—and to impart those findings to the next generation of
veterinarians and researchers. As a partner in one of the world’s
great biomedical research and training centers, Penn Vet helps
both animals and people everywhere live longer, healthier
lives.Truly, biomedical research is the unsung hero of our
ongoing success story.

“h

Õ

The Promise of Stem Cell Research

Õ

Building a Better Gene Trap

Õ Õ

One area of research that is widely known
to most people is the study of stem cells, the
Experiments to
Drug Development
use of which is generating much optimism
Study Development
and Toxicity Tests
for treating human and animal diseases. For
and Gene Control
years, researchers at Penn and elsewhere
Cultured Pluripotent
have sought to understand why the body
Stem Cells
repairs and replaces some tissues, but not
others. After analyzing apparently indiscriminant cell-repair mechanisms, scientists have
focused on stem cells; these cells have a speTissues/Cells for Therapy
cial capacity to renew themselves and form
a variety of specialized cell types. Stem cells
are capable of growing into any of the 300
different kinds of cells in the body.
Scientists distinguish between two types
of stem cells: adult and embryonic. Adult
stem cells exist in developed tissues in animals or humans after birth, supplying their
specific tissue with replacement cells
throughout life. (For example, our blood
stem cells produce five million cells per secBone Marrow
Pancreatic
Heart Muscle
Nerve Cells
ond.) Adult stem cells can be isolated from
Islet Cells
Cells
many parts of the body, including the brain,
but most commonly they are drawn from
the marrow in some bones. Compared to
Courtesy of the NIH
embryonic stem cells, which come from
Reproduction and director of the School’s Center for
embryos and can make replacement cells for any tissue,
Animal Transgenesis and Germ Cell Research, acknowladult stem cells are normally dedicated to making cells for
edges that much of the research in her lab has its roots in
one particular type. In other words, adult skin stem cells
the germ cell technology that Dr. Brinster developed in
usually can only make skin, not brain or blood cells. Most
the mid-1990s. Dr. Dobrinski is applying information
experts agree, though, that the potential of stem cells to
derived from Dr. Brinster’s work in the mouse to nonprevent, diagnose and treat disease in both animals and
rodent animals, ultimately to improve the health and propeople is seemingly unlimited.
Dr. Ralph Brinster,V’60, GR’64, Richard King
ductivity of farm animals through transplantation of male
Mellon Professor of Reproductive Physiology, is a pioneer
germ cells whose genes have been manipulated.These
in the transplantation of certain stem cells known as
genetically altered animals and plants are called “trans“germ cells,” which are the reproductive cells of the
genic” and can be of enormous value in medicine and
body—eggs in females and sperm in males. “Stem cell
agriculture. In fact, transgenic animals were first created
research is an area that has a lot of promise in terms of
here at Penn, in 1981.
biology and medicine,” he explained. “For example, stem
“Going into the male germ-line for particular stem
cells are responsible for maintenance of many tissues and
cells was a very fascinating question because then the animedical conditions, including cancer, so understanding
mal could just breed normally and transmit that fixed gene
stem cells will help us understand disease.”
or changed gene to its offspring,” said Dr. Dobrinski.“In
Dr. Brinster made international news in 1994 when he
order to do that, to a certain degree we had to reinvent the
transplanted the stem cells of one mouse into another.
wheel:We had to redevelop the transplantation technique
When the stem cells became germ cells, they retained the
[used in mice] because it doesn’t work the same way in
genes of the donor mouse. In an article published in the
pigs or goats.We had to learn about those stem cells
February 2006 issue of Nature Clinical Practice, Dr. Brinster
because we don’t have the same reagents or antibodies
describes a technique in which donor sperm cells from a
available as we have for mouse stem cells.” One aspect of
fertile male mouse can be transplanted to the testes of an
this work is the exploration of germ-line stem cell biology
infertile male, where they can restore fertility. Eventually,
to develop a new approach to transgenesis in domestic anithis procedure can offer hope to men who have become
mals through the alteration of the male germ-line.
sterile following chemotherapy or radiation treatment.
In the November/December 2005 issue of the Journal
Working at New Bolton Center in Kennett Square, Pa.,
of Andrology, Dr. Dobrinski and her colleagues relate
Dr. Ina Dobrinski, Dr.med.vet., M.V.Sc., Ph.D.,
another way in which changing the genes of certain aniMarion Dilly and David George Jones Chair in Animal
mals can be beneficial. “. . .Transgenic pigs play a central
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Dr. Oyama and
Rudy

Cardiac cellular transplantation could have a marked effect in
treating dilated cardiomyopathy, or DCM, one of the most common
acquired heart diseases in large dogs. Some breeds, such as
Dobermans, great Danes and boxers, are particularly prone to it.
DCM causes the heart muscle to lose strength and fail to pump
blood properly, and can eventually lead to heart failure.To identify
genes that may play a role in the process of the disease, Dr. Oyama
and his colleagues at Illinois used a commercially available gene chip,
or microarray, designed for dogs—the GeneChip Canine Genome

a process known as cardiac
cellular transplantation.
But the fundamental biological processes that govern the behavior of these
cells remains a mystery, as
does the long-term efficacy of the procedure.
“I think people get
excited about it because
of the huge potential that
Array—a 1.5-inch square that contains more than 23,000 genes.
it has,” Dr. Oyama said.
“Even in people, it’s an
When exposed to the genetic material from Doberman dogs that
area about which very lithad died from heart disease, genes on the chip fluoresced, or lit up,
tle is known.When
if they were active in the sample.The researchers knew the nature
they’re doing stem cell
and location of the genes on the chip, so they could identify the
transplants in people, yes,
it appears to improve the
active genes in the samples and determine their level of activity by
heart function, but when
the brightness of the fluorescence. Essentially all 23,000 genes,
you ask the scientists
tested at once, were narrowed down to 167 genes that could play
‘How is it doing that?’
a role in the development of DCM.
nobody knows.They don’t
have any idea. Cells go in
there, and somehow
Photo by Sabina Louise Pierce
role as a potential source of tissues and organs for [transthey’re making the heart function better.”
plantation] to humans and are of increasing interest as
Cardiac cellular transplantation already has been permodels for biomedical research. Similarly, transgenic dairy
formed in people who have suffered from heart attacks.
goats are of significant economic value for the production
The early results suggest that a variety of adult stem cells
of biopharmaceutical proteins in their milk. . . .”
implanted in the heart are able to survive and grow into
Another article co-authored by Dr. Dobrinski in the
cardiac-like muscle tissue, “rebuilding the heart one cell at
same issue of the Journal of Andrology (published online
a time,” as Dr. Oyama wrote in Veterinary Medicine
ahead of print) explains how stem cell transplantation can
(February 1, 2005).
help conserve species of animals that are endangered due
Because a particular type of heart disease in dogs
to loss of genetic diversity. “We are attempting to develop
involves much more of the heart than in people with a
. . . stem cell transplantation [of undifferentiated sperm
similar disease, local injections of cells during surgery—
cells] in the cat as a tool to preserve and propagate male
which is often used for people—would be inefficient for
dogs. “If the whole heart is diseased, that’s a lot harder. So
germplasm [DNA] from genetically valuable animals, be
now you have to put in maybe 20 or 30 of these little
they threatened wild species or lines of cats used as models
injections everywhere and hope that the cells spread out.
for inherited diseases.”
Every time you poke the heart, it’s conceivable that the
Mending a Broken Heart
heart will have abnormal heart rhythms, it can bruise the
heart muscle and create lots of other problems,” Dr.
Some 35 miles away from the Center for Animal TransOyama said.
genesis and Germ Cell Research, Dr. Mark Oyama,
associate professor of cardiology at the Ryan Veterinary
One Medicine
Hospital, has studied how stem cell research might be used
to treat dogs with heart disease. Even with the development One of the reasons that Dr. Oyama chose to come to Penn
of new technology and medications, even with an everwas its unique position as part of a vast network of biobroadening knowledge base about the causes and courses of medical research facilities—and he has already begun to
heart disease, illness and death in dogs with heart problems
take full advantage of the extraordinary opportunities this
remains high. According to the American Veterinary
offers. A certain kind of heart-valve disease in dogs resemMedical Association, approximately 3.2 million dogs in the
bles that which occurs in some people who have taken the
United States that have annual veterinary examinations
diet drug “phen-fen” (a combination of phentermine and
suffer from some form of “acquired” heart disease and may
fenfluramine). Dr. Oyama has begun work with Robert J.
be in heart failure.
Levy, M.D.,William J. Rashkind Endowed Chair in
Dr. Oyama came to Penn last year from the University of Pediatric Cardiology at the Children’s Hospital of
Illinois College of Veterinary Medicine, where he investiPhiladelphia, in looking at valve tissue in humans and trygated how damaged heart cells in dogs could be repaired by ing to better understand how a certain pathway involving
transplanting the animals’ own stem cells into their hearts— serotonin and transforming growth factor beta contributes
8
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to the disease. (Serotonin is a neurotransmitter believed to
play an important role in the regulation of mood, sleep,
vomiting, sexuality and appetite. Transforming growth factor
beta is one of many characterized growth factors that are
involved in tissue development, cell differentiation, embryonic development and many other signaling pathways.)
“We are doing some combined experiments to compare
mitral disease in dogs with mitral disease in humans,” Dr.
Oyama explained.“If similarities exist, we can look at the
dog as a model of disease for people, as well as apply what
we know about the human disease to figure out why older,
small-breed dogs are so predisposed to the disease.This comparative study hopes to merge Dr. Levy’s expertise in serotonin valve disease with our expertise in the canine disease.”

Bred in the Bone
Cardiac tissue is not the only subject of stem cell research
at the School. In the Section of Surgery of the Department
of Clinical Studies–Philadelphia, Dr. Susan Volk,V’95,
GR’99, lecturer, has joined the faculty at Penn’s Medical
and Dental schools in studying how stem cells derived
from bone marrow can eventually become bone cells.
Most injured tissues heal by forming a scar, but injured
bone heals by actually forming new bone. Even in its
uninjured state, bone undergoes constant remodeling to
maintain its ability to move and support the body and to
sustain constant calcium levels. Both these processes—healing and remodeling—are dependent on undifferentiated
bone cells, as well as stem cells that can be induced to form
bone. If the recruitment, differentiation and/or induction
steps of new bone formation do not occur, the body can
develop orthopaedic disorders such as osteoporosis and
slow- or non-healing fractures. Because people in industrialized countries are living longer, orthopaedic disease is
having a greater economic impact on health-care resources.
This factor, as well as the significant decrease in quality of
life associated with these conditions, has made studies
involving orthopaedic disease a high priority within the
field of biomedical research.
Delayed bone healing in dogs requires extended medical
care, with prolonged patient illness and increased client
expense. Bone grafts using tissue from the patient’s own
body are frequently used to help bone union after surgery.
Several concerns, however, are associated with graft harvesting: problems or infection at the collection site,
increased anesthetic time and limited volume and donor
cell number. Bone-marrow stem cells (MSCs) are an
accepted source of bone-forming cells recruited during
normal bone growth, remodeling and fracture repair.
Therefore, they are logical agents for use in cell-based therapies where induced bone growth is required. Pure populations of culture-expanded, inducible MSCs can be a potent
alternative to bone grafting with fewer complications.
Although MSCs enhance the repair of canine fractures
and bone gaps, the specific inducers necessary to cause
canine MSCs to become bone-forming cells have yet to be
identified. Although MSCs from all species studied can be
induced to eventually form bone cells, the potency of

inducers varies markedly from one species to the next.The
work of Dr.Volk and her colleagues, published in the
October 2005 issue of the American Journal of Veterinary
Research, suggests that differences exist in the most efficient
inducers of bone growth among species. “Defining which
growth factors are most efficient to induce [bone formation] in these cells has important clinical implications for
their use in cell-based therapies. In addition, we are defining differences that exist in the differentiation capacity of
these cells based on their source (i.e., site of bone-marrow
harvest and age of donor), which has important implications for the development of MSC-based therapies in our
small-animal surgical patients, as well as in humans,” Dr.
Volk explained.
In addition to Dr.Volk’s interest in MSCs for orthopaedic
applications, she is also investigating their use for soft-tissue
surgical applications. In collaboration with Drs. Kenneth
Liechty and Alan Flake at the Children’s Institute for
Surgical Science, Children’s Hospital of Philadelphia, she
has focused on establishing their effect in the treatment of
oxygen-deprived (ischemic) wounds and dissecting mechanisms of their therapeutic effects. Complicated wound
healing imposes a formidable clinical challenge in both
human and veterinary medicine, with prolonged hospitalization and substantial health-care expenditure.To date,
effective therapies for ischemic ulcers and other chronic
non-healing wounds are lacking. Dr.Volk’s research suggests
that MSCs directly participate in wound healing and indirectly influence surrounding cells to improve healing of
ischemic wounds. Studies are underway to characterize
how topical application of MSCs can improve the phases
of healing in ischemic wounds. Knowledge about tissue
engineering gained from this research can provide substantial insight into molecular mechanisms critical for healing
chronic wounds and other ischemic tissues.

Full Steam Ahead
Research is the cornerstone on which Penn—and any
other research university, for that matter—must build its
future, on which medical science itself is perpetually balanced. Stem cell technology has already revolutionized
modern biology and promises to provide unique opportunities in understanding mechanisms behind basic biological
processes and in the treatment of disease. Among its countless applications in human and veterinary science,
researchers hope to eventually use stem cells to repair
spinal cords; cure Crohn’s, Alzheimer’s and Parkinson’s diseases; re-grow arteries and limbs; replace damaged kidneys
and hearts; cure diabetes by substituting nonfunctioning
pancreatic cells; restore vision and hearing; and treat
leukemia, lymphoma and brain cancer. In fact, most of
these treatments have already been studied, and with promising results. Granted, years of additional research are still
necessary to realize this technology’s full therapeutic potential, but work at Penn Vet in the laboratories of researchers
like Drs. Brinster, Dobrinski, Oyama and Volk—and in labs
across campus and around the world—is proceeding full
steam ahead.
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